Steroid hormone synthesis in mitochondria

Molecular and Cellular Endocrinology

Volumn 379, Issue 1-2, 2013, Pages 62-73

  Miller, Walter L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cholesterol side chain cleavage; Cholesterol transport; Outer mitochondrial membrane; Steroidogenesis; Steroidogenic acute regulatory protein; Vitamin D

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE SYNTHASE; CHOLESTEROL; CYCLIC AMP DEPENDENT PROTEIN KINASE REGULATORY SUBUNIT IALPHA; CYTOCHROME P450; FERREDOXIN; FERREDOXIN NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE REDUCTASE; MICROTUBULE ASSOCIATED PROTEIN 1; PREGNENOLONE; STEROID 11BETA MONOOXYGENASE; STEROID HORMONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; VITAMIN D; VOLTAGE DEPENDENT ANION CHANNEL 1;

ARTICLE; CHOLESTEROL TRANSPORT; ENDOSOME; HUMAN; KIDNEY TUBULE CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; OUTER MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; STEROIDOGENESIS;

1,25 DIHYDROXY VITAMIN D (CALCITRIOL); 1,25(OH)(2)D; 18KDA TRANSLOCATOR PROTEIN; 3-HYDROXY-3-METHYLGLUTARYL CO-ENZYME A; 3Β-HYDROXYSTEROID DEHYDROGENASE; 3ΒHSD; ACAT; ACTH; ACYL TRANSFERASE; ADENINE NUCLEOTIDE TRANSPORTER; ADRENOCORTICOTROPIC HORMONE; ANT; CHOLESTEROL RECOGNITION AMINO ACID CONSENSUS DOMAIN; CHOLESTEROL SIDE CHAIN CLEAVAGE; CHOLESTEROL TRANSPORT; CRAC; ENDOPLASMIC RETICULUM; ER; FAD; FLAVIN ADENINE DINUCLEOTIDE; HDL; HIGH DENSITY LIPOPROTEIS; HMGCOA; HORMONE-SENSITIVE NEUTRAL LIPASE; HSL; IMM; IMS; INNER MITOCHONDRIAL MEMBRANE; INTRAMEMBRANOUS SPACE; KM; LAL; LDL; LH; LOW-DENSITY LIPOPROTEINS; LUTEINIZING HORMONE; LYSOSOMAL ACID LIPASE; MENTAL; MENTHO; METASTATIC LYMPH NODE CLONE 64; MICHAELIS CONSTANT; MITOCHONDRIAL CYTOCHROME P450 SPECIFIC FOR CHOLESTEROL SIDE-CHAIN CLEAVAGE; MLN64; MLN64 N-TERMINAL; MLN64 N-TERMINAL DOMAIN HOMOLOGUE; NADPH; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NIEMANN PICK TYPE C; NPC; OMM; OUTER MITOCHONDRIAL MEMBRANE; P450SCC; PAP7; PARATHYROID HORMONE; PBR; PCP; PERIPHERAL BENZODIAZEPINE RECEPTOR; PHOSPHATE CARRIER PROTEIN; PKA; PKAR1A; PRAX1; PROTEIN KINASE A; PROTEIN KINASE A REGULATORY SUBUNIT 1Α; PTH; SCAVENGER RECEPTOR B1; SF1; SOAT; SR-B1; SREBPS; STAR; STAR-RELATED LIPID TRANSFER DOMAIN; START; STEROIDOGENESIS; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STEROIDOGENIC FACTOR 1; STEROL O-ACETYLTRANSFERASE; STEROL REGULATORY ELEMENT BINDING PROTEINS; TSPO; TSPO-ASSOCIATED PROTEIN 1; TSPO-ASSOCIATED PROTEIN 7 (ACBD3); VDAC1; VITAMIN D; VOLTAGE-DEPENDENT ANION CHANNEL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADRENAL CORTEX HORMONES; BIOLOGICAL TRANSPORT; CHOLESTEROL; CHOLESTEROL SIDE-CHAIN CLEAVAGE ENZYME; CYCLIC AMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNITS; GONADAL STEROID HORMONES; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PHOSPHOPROTEINS; PLACENTAL HORMONES; PREGNENOLONE; RECEPTORS, GABA; VITAMIN D; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84884530635     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.04.014     Document Type: Article

References (135)

1. Agarwal A.K., Auchus R.J. Cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 2005, 146:2531-2538.
2. Alpy F., Tomasetto C. MLN64 and MENTHO, two mediators of endosomal cholesterol transport. Biochem. Soc. Trans. 2006, 34:343-345.
3. Alpy F., Stoeckel M.E., Dierich A., Escola J.M., Wendling C., Chenard M.P., Vanier M.T., Gruenberg J., Tomasetto C., Rio M.C. The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein. J. Biol. Chem. 2001, 276:4261-4269.
4. Alpy F., Wendling C., Rio M.C., Tomasetto C. MENTHO, a MLN64 homologue devoid of the START domain. J. Biol. Chem. 2002, 277:50780-50787.
5. Annalora A.J., Goodin D.B., Hong W.X., Zhang Q., Johnson E.F., Stout C.D. Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism. J. Mol. Biol. 2010, 396:441-451.
6. Arakane F., Sugawara T., Nishino H., Liu Z., Holt J.A., Pain D., Stocco D.M., Miller W.L., Strauss J.F. Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc. Natl. Acad. Sci. USA 1996, 93:13731-13736.
7. Arakane F., King S.R., Du Y., Kallen C.B., Walsh L.P., Watari H., Stocco D.M., Strauss J.F. Phosphorylation of steroidogenic acute regulatory protein (StAR) modulates its steroidogenic activity. J. Biol. Chem. 1997, 272:32656-32662.
8. Artemenko I.P., Zhao D., Hales D.B., Hales K.H., Jefcoate C.R. Mitochondrial processing of newly synthesized steroidogenic acute regulatory protein (StAR), but not total StAR, mediates cholesterol transfer to cytochrome P450 side chain cleavage enzyme in adrenal cells. J. Biol. Chem. 2001, 276:46583-46596.
9. Auchus R.J., Lee T.C., Miller W.L. Cytochrome b5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J. Biol. Chem. 1998, 273:3158-3165.
10. Baker B.Y., Yaworsky D.C., Miller W.L. A pH-dependent molten globule transition is required for activity of the steroidogenic acute regulatory protein, StAR. J. Biol. Chem. 2005, 280:41753-41760.
11. Baker B.Y., Lin L., Kim C.J., Raza J., Smith C.P., Miller W.L., Achermann J.C. Nonclassic congenital lipoid adrenal hyperplasia: a new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J. Clin. Endocrinol. Metab. 2006, 91:4781-4785.
12. Baker B.Y., Epand R.F., Epand R.M., Miller W.L. Cholesterol binding does not predict activity of the steroidogenic acute regulatory protein, StAR. J. Biol. Chem. 2007, 282:10223-10232.
13. Bayrhuber M., Meins T., Habeck M., Becker S., Giller K., Villinger S., Vonrhein C., Griesinger C., Zweckstetter M., Zeth K. Structure of the human voltage-dependent anion channel. Proc. Natl. Acad. Sci. USA 2008, 105:15370-15375.
14. Black S.M., Harikrishna J.A., Szklarz G.D., Miller W.L. The mitochondrial environment is required for activity of the cholesterol side-chain cleavage enzyme, cytochrome P450scc. Proc. Natl. Acad. Sci. USA 1994, 91:7247-7251.
15. Bose H.S., Sugawara T., Strauss J.F., Miller W.L. The pathophysiology and genetics of congenital lipoid adrenal hyperplasia. N. Engl. J. Med. 1996, 335:1870-1878.
16. Bose H.S., Pescovitz O.H., Miller W.L. Spontaneous feminization in a 46XX female patient with congenital lipoid adrenal hyperplasia caused by a homozygous frame-shift mutation in the steroidogenic acute regulatory protein. J. Clin. Endocrinol. Metab. 1997, 82:1511-1515.
17. Bose H.S., Whittal R.M., Baldwin M.A., Miller W.L. The active form of the steroidogenic acute regulatory protein, StAR, appears to be a molten globule. Proc. Natl. Acad. Sci. USA 1999, 96:7250-7255.
18. Bose H.S., Whittal R.M., Huang M.C., Baldwin M.A., Miller W.L. N-218 MLN64, a protein with StAR-like steroidogenic activity, is folded and cleaved similarly to StAR. Biochemistry 2000, 39:11722-11731.
19. Bose H.S., Lingappa V.R., Miller W.L. Rapid regulation of steroidogenesis by mitochondrial protein import. Nature 2002, 417:87-91.
20. Bose H.S., Whittal R.M., Ran Y., Bose M., Baker B.Y., Miller W.L. StAR-like activity and molten globule behavior of StARD6, a male germ-line protein. Biochemistry 2008, 47:2277-2288.
21. Bose M., Whittal R.M., Miller W.L., Bose H.S. Steroidogenic activity of StAR requires contact with mitochondrial VDAC1 and phosphate carrier protein. J. Biol. Chem. 2008, 283:8837-8845.
22. Brandt M.E., Vickery L.E. Expression and characterization of human mitochondrial ferredoxin reductase in Escherichia coli. Arch. Biochem. Biophys. 1992, 294:735-740.
23. Brdiczka D.G., Zorov D.B., Sheu S.S. Mitochondrial contact sites: their role in energy metabolism and apoptosis. Biochim. Biophys. Acta 2006, 1762:148-163.
24. Brentano S.T., Black S.M., Lin D., Miller W.L. CAMP post-transcriptionally diminishes the abundance of adrenodoxin reductase mRNA. Proc. Natl. Acad. Sci. USA 1992, 89:4099-4103.
25. Cali J.J., Hsieh C.L., Francke U., Russell D.W. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 1991, 266:7779-7783.
26. Cao P., Bulow H., Dumas B., Bernhardt R. Construction and characterization of a catalytic fusion protein system: P-45011-adrenodoxin reductase-adrenodoxin. Biochim. Biophys. Acta 2000, 1476:253-264.
27. Charman M., Kennedy B.E., Osborne N., Karten B. MLN64 mediates egress of cholesterol from endosomes to mitochondria in the absence of functional Niemann-Pick Type C1 protein. J. Lipid Res. 2010, 51:1023-1034.
28. Chen K.S., Prahl J.M., DeLuca H.F. Isolation and expression of human 1,25-dihydroxyvitamin D3 24-hydroxylase cDNA. Proc. Natl. Acad. Sci. USA 1993, 90:4543-4547.
29. Cheng J.B., Motola D.L., Mangelsdorf D.J., Russell D.W. De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J. Biol. Chem. 2003, 278:38084-38093.
30. Cheng J.B., Levine M.A., Bell N.H., Mangelsdorf D.J., Russell D.W. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA 2004, 101:7711-7715.
31. Cherradi N., Chambaz E.M., Defaye G. Organization of 3β-hydroxysteroid dehydrogenase/isomerase and cytochrome P450scc into a catalytically active molecular complex in bovine adrenocortical mitochondria. J. Steroid Biochem. Mol. Biol. 1995, 55:507-514.
32. Cherradi N., Rossier M.F., Vallotton M.B., Timberg R., Friedberg I., Orly J., Wang X.J., Stocco D.M., Capponi A.M. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome P450scc and 3-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J. Biol. Chem. 1997, 272:7899-7907.
33. Clark B.J. The mammalian START domain protein family in lipid transport in health and disease. J. Endocrinol. 2012, 212:257-275.
34. Clark B.J., Wells J., King S.R., Stocco D.M. The purification, cloning and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 cells mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 1994, 269:28314-28322.
35. Dauber A., Nguyen T.T., Sochett E., Cole D.E., Horst R., Abrams S.A., Carpenter T.O., Hirschhorn J.N. Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia. J. Clin. Endocrinol. Metab. 2012, 97:E268-E274.
36. Dilworth F.J., Black S.M., Guo Y.D., Miller W.L., Jones G. Construction of a P450c27 fusion enzyme - a useful tool for analysis of vitamin D3-25-hydroxylase activity. Biochem. J. 1996, 320:267-271.
37. Dobs A.S., Schrott H., Davidson M.H., Bays H., Stein E.A., Kush D., Wu M., Mitchel Y., Illingworth R.D. Effects of high-dose simvastatin on adrenal and gonadal steroidogenesis in men with hypercholesterolemia. Metabolism 2000, 49:1234-1238.
38. Dong Q., Miller W.L. Vitamin D 25-hydroxylase deficiency. Mol. Genet. Metab. 2004, 83:197-198.
39. Dyson M.T., Kowalewski M.P., Manna P.R., Stocco D.M. The differential regulation of steroidogenic acute regulatory protein-mediated steroidogenesis by type I and type II PKA in MA-10 cells. Mol. Cell. Endocrinol. 2009, 300:94-103.
40. Edouard T., Alos N., Chabot G., Roughley P., Glorieux F.H., Rauch F. Short- and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol. J. Clin. Endocrinol. Metab. 2011, 96:82-89.
41. Epstein L.F., Orme-Johnson N.R. Regulation of steroid hormone biosynthesis. Identification of precursors of a phosphoprotein targeted to the mitochondrion in stimulated rat adrenal cortex cells. J. Biol. Chem. 1991, 266:19739-19745.
42. Fan J., Liu J., Culty M., Papadopoulos V. Acyl-coenzyme A binding domain containing 3 (ACBD3; PAP7; GCP60): an emerging signaling molecule. Prog. Lipid Res. 2010, 49:218-234.
43. Fardella C.E., Miller W.L. Molecular biology of mineralocorticoid metabolism. Annu. Rev. Nutr. 1996, 16:443-470.
44. Feldman D., Malloy P.J., Miller W.L. Genetic disorders of vitamin D synthesis and action. Genetics of Bone Biology and Skeletal 2013, 537-552. Academic Press (Elsevier), London, UK. R.V. Thakker, M.P. Whyte, J.A. Eisman, T. Igarashi (Eds.).
45. Freeman M.R., Dobritsa A., Gaines P., Segraves W.A., Carlson J.R. The dare gene: steroid hormone production, olfactory behavior, and neural degeneration in Drosophila. Development 1999, 126:4591-4602.
46. Fu G.K., Lin D., Zhang M.Y.H., Bikle D.D., Shackleton C.H.L., Miller W.L., Portale A.A. Cloning of human 25-hydroxyvitamin D 1-hydroxylase and mutations causing vitamin D-dependent rickets type I. Mol. Endocrinol. 1997, 11:1961-1970.
47. Fu G.K., Portale A.A., Miller W.L. Complete structure of the human gene for the vitamin D 1hydroxylase, P450clDNA. Cell Biol. 1997, 16:1499-1507.
48. Fujieda K., Tajima T., Nakae J., Sageshima S., Tachibana K., Suwa S., Sugawara T., Strauss J.F. Spontaneous puberty in 46, XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J. Clin. Invest. 1997, 99:1265-1271.
49. Gizard F., Lavallee B., DeWitte F., Teissier E., Staels B., Hum D.W. The transcriptional regulating protein of 132 kDa (TReP-132) enhances P450scc gene transcription through interaction with steroidogenic factor-1 in human adrenal cells. J. Biol. Chem. 2002, 277:39144-39155.
50. Gucev Z., Tee M.K., Chitayat D., Wherrett D., Miller W.L. Distinguishing deficiencies of StAR and P450scc causing neonatal adrenal failure. J. Pediatr. 2013, 162:819-822.
51. Harikrishna J.A., Black S.M., Szklarz G.D., Miller W.L. Construction and function of fusion enzymes of the human cytochrome P450scc system. DNA Cell Biol. 1993, 12:371-379.
52. Hasegawa T., Zhao L.P., Caron K.M., Majdic G., Suzuki T., Shizawa S., Sasano H., Parker K.L. Developmental roles of the steroidogenic acute regulatory protein (StAR) as revealed by StAR knockout mice. Mol. Endocrinol. 2000, 14:1462-1471.
53. Hauet T., Yao Z.X., Bose H.S., Wall C.T., Han Z., Li W., Hales D.B., Miller W.L., Culty M., Papadopoulos V. Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria. Mol. Endocrinol. 2005, 19:540-554.
54. Henderson Y.C., Frederick M.J., Jayakumar A., Choi Y., Wang M.T., Kang Y., Evans R., Spring P.M., Uesugi M., Clayman G.L. Human LBP-32/MGR is a repressor of the P450scc in human choriocarcinoma cell line JEG-3. Placenta 2007, 28:152-160.
55. Hiller S., Garces R.G., Malia T.J., Orekhov V.Y., Colombini M., Wagner G. Solution structure of the integral human membrane protein VDAC-1 in detergent micelles. Science 2008, 321:1206-1210.
56. Hu M.C., Hsu N.C., El Hadj N.B., Pai C.I., Chu H.P., Wang C.K.L., Chung B.C. Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1. Mol. Endocrinol. 2002, 16:1943-1950.
57. Huang N., Miller W.L. Cloning of factors related to HIV-inducible LBP proteins that regulate steroidogenic factor-1-independent human placental transcription of the cholesterol side-chain cleavage enzyme, P450scc. J. Biol. Chem. 2000, 275:2852-2858.
58. Illingworth D., Kenney T.A., Orwoll E.S. Adrenal function in heterozygous and homozygous hypobetalipoproteinemia. J. Clin. Endocrinol. Metab. 1982, 54:27-33.
59. Jamin N., Neumann J.M., Ostuni M.A., Vu T.K., Yao Z.X., Murail S., Robert J.C., Giatzakis C., Papadopoulos V., Lacapere J.J. Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol. Endocrinol. 2005, 19:588-594.
60. Jo Y., King S.R., Khan S.A., Stocco D.M. Involvement of protein kinase C and cyclic adenosine 3',5'-monophosphate-dependent kinase in steroidogenic acute regulatory protein expression and steroid biosynthesis in Leydig cells. Biol. Reprod. 2005, 73:244-255.
61. Joseph-Liauzun E., Delmas P., Shire D., Ferrara P. Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J. Biol. Chem. 1998, 273:2146-2152.
62. Kim C.J., Kaplan L.E., Perwad F., Huang N., Sharma A., Choi Y., Miller W.L., Portale A.A. Mutations in the gene for 1-hydroxylase, CYP27B1, in patients with vitamin D 1-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 2007, 92:3177-3182.
63. Kim J.M., Choi J.H., Lee J.H., Kim G.H., Lee B.H., Kim H.S., Shin J.H., Shin C.H., Kim C.J., Yu J., Lee D.Y., Cho W.K., Suh B.K., Lee J.E., Chung H.R., Yoo H.W. High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia. Eur. J. Endocrinol. 2011, 165:771-778.
64. Kishida T., Kostetskii I., Zhang Z., Martinez F., Liu P., Walkley S.U., Dwyer N.K., Blanchette-Mackie E.J., Radice G.L., Strauss J.F. Targeted mutation of the MLN64 START domain causes only modest alterations in cellular sterol metabolism. J. Biol. Chem. 2004, 279:19276-19285.
65. Korkhov V.M., Sachse C., Short J.M., Tate C.G. Three-dimensional structure of TspO by electron cryomicroscopy of helical crystals. Structure 2010, 18:677-687.
66. Kwon H.J., Abi-Mosleh L., Wang M.L., Deisenhofer J., Goldstein J.L., Brown M.S., Infante R.E. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell 2009, 137:1213-1224.
67. Lacapere J.J., Papadopoulos V. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids 2003, 68:569-585.
68. Lee T.C., Miller W.L., Auchus R.J. Medroxyprogesterone acetate and dexamethasone are competitive inhibitors of different human steroidogenic enzymes. J. Clin. Endocrinol. Metab. 1999, 84:2104-2110.
69. Leitersdorf E., Reshef A., Meiner V., Levitzki R., Schwartz S.P., Dann E.J., Berkman N., Cali J.J., Klapholz L., Berginer V.M. Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin. J. Clin. Invest. 1993, 91:2488-2496.
70. Li H., Yao Z., Degenhardt B., Teper G., Papadopoulos V. Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc. Natl. Acad. Sci. USA 2001, 98:1267-1272.
71. Lin D., Gitelman S.E., Saenger P., Miller W.L. Normal genes for the cholesterol side chain cleavage enzyme, P450scc, in congenital lipoid adrenal hyperplasia. J. Clin. Invest. 1991, 88:1955-1962.
72. Lin D., Chang Y.J., Strauss J.F., Miller W.L. The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics 1993, 18:643-650.
73. Lin D., Sugawara T., Strauss J.F., Clark B.J., Stocco D.M., Saenger P., Rogol A., Miller W.L. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995, 267:1828-1831.
74. Liu J., Rone M.B., Papadopoulos V. Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J. Biol. Chem. 2006, 281:38879-38893.
75. Lohse P., Maas S., Sewell A.C., van Diggelen O.P., Seidel D. Molecular defects underlying Wolman disease appear to be more heterogeneous than those resulting in cholesteryl ester storage disease. J. Lipid Res. 1999, 40:221-228.
76. Manna P.R., Dyson M.T., Stocco D.M. Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives. Mol. Hum. Reprod. 2009, 15:321-333.
77. Mannella C.A., Forte M., Colombini M. Toward the molecular structure of the mitochondrial channel, VDAC. J. Bioenergy Biomembr. 1992, 24:7-19.
78. Mast N., Annalora A.J., Lodowski D.T., Palczewski K., Stout C.D., Pikuleva I.A. Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. J. Biol. Chem. 2011, 286:5607-5613.
79. Mathieu A.P., Fleury A., Ducharme L., Lavigne P., LeHoux J.G. Insights into steroidogenic acute regulatory protein (StAR)-dependent cholesterol transfer in mitochondria: evidence from molecular modeling and structure-based thermodynamics supporting the existence of partially unfolded states of StAR. J. Mol. Endocrinol. 2002, 29:327-345.
80. McEnery M.W., Snowman A.M., Trifiletti R.R., Snyder S.H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltagedependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. USA 1992, 89:3170-3174.
81. Midzak A., Akula N., Lecanu L., Papadopoulos V. Novel androstenetriol interacts with the mitochondrial translocator protein and controls steroidogenesis. J. Biol. Chem. 2011, 286:9875-9887.
82. Miller W.L. Congenital lipoid adrenal hyperplasia: the human gene knockout of the steroidogenic acute regulatory protein. J. Mol. Endocrinol. 1997, 19:227-240.
83. Miller W.L. Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 2005, 146:2544-2550.
84. Miller W.L. StAR search-what we know about how the steroidogenic acute regulatory protein mediates mitochondrial cholesterol import. Mol. Endocrinol. 2007, 21:589-601.
85. Miller W.L., Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr. Rev. 2011, 32:81-151.
86. Miller W.L., Bose H.S. Early steps in steroidogenesis: intracellular cholesterol trafficking. J. Lipid Res. 2011, 52:2111-2135.
87. Muller A., Muller J.J., Muller Y.A., Uhlmann H., Bernhardt R., Heinemann U. New aspects of electron transfer revealed by the crystal structure of a truncated bovine adrenodoxin, Adx(4-108). Structure 1998, 6:269-280.
88. Nakae J., Tajima T., Sugawara T., Arakane F., Hanaki K., Hotsubo T., Igarashi N., Igarashi Y., Ishii T., Koda N., Kondo T., Kohno H., Nakagawa Y., Tachibana K., Takeshima Y., Tsubouchi K., Strauss J.F., Fujieda K. Analysis of the steroidogenic acute regulatory protein (StAR) gene in Japanese patients with congential lipoid adrenal hyperplasia. Hum. Mol. Genet. 1997, 6:571-576.
89. Nebert D.W., Wikvall K., Miller W.L. Human cytochromes P450 in health and disease. Phil. Trans. R. Soc. B 2013, 368:20120431. http://dx.doi.org/10.1098/rstb.2012.0431.
90. Norman A.W. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am. J. Clin. Nutr. 1998, 67:1108-1110.
91. 3 24-hydroxylase. FEBS Lett. 1991, 278:195-198.
92. Olvera-Sanchez S., Espinosa-Garcia M.T., Monreal J., Flores-Herrera O., Martinez F. Mitochondrial heat shock protein participates in placental steroidogenesis. Placenta 2011, 32:222-229.
93. Papadopoulos V., Miller W.L. Role of mitochondria in steroidogenesis. Best practice & research. Clin. Endocrinol. Metab. 2012, 26:771-790.
94. Papadopoulos V., Amri H., Li H., Boujrad N., Vidic B., Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 1997, 272:32129-32135.
95. Papadopoulos V., Baraldi M., Guilarte T.R., Knudsen T.B., Lacapere J.J., Lindemann P., Norenberg M.D., Nutt D., Weizman A., Zhang M.R., Gavish M. Receptor based on its structure and molecular function. Trends Pharmacol. Sci. 2006, 27:402-409.
96. Pawlak K.J., Prasad M., Thomas J.L., Whittal R.M., Bose H.S. Inner mitochondrial translocase Tim50 interacts with 3β-hydroxysteroid dehydrogenase type 2 to regulate adrenal and gonadal steroidogenesis. J. Biol. Chem. 2011, 286:39130-39140.
97. Pelletier G., Li S., Luu-The V., Tremblay Y., Belanger A., Labrie F. Immunoelectron microscopic localization of three key steroidogenic enzymes (cytochrome P450(scc), 3β-hydroxysteroid dehydrogenase and cytochrome P450(c17)) in rat adrenal cortex and gonads. J. Endocrinol. 2001, 171:373-383.
98. Penning T.M. Molecular endocrinology of hydroxysteroid dehydrogenases. Endocr. Rev. 1997, 18:281-305.
99. Pon L.A., Orme-Johnson N.R. Acute stimulation of steroidogenesis in corpus luteum and adrenal cortex by peptide hormones. J. Biol. Chem. 1986, 261:6594-6599.
100. Pon L.A., Hartigan J.A., Orme-Johnson N.R. Acute ACTH regulation of adrenal corticosteroid biosynthesis: rapid accumulation of a phosphoprotein. J. Biol. Chem. 1986, 261:13309-13316.
101. Porter F.D., Herman G.E. Malformation syndromes caused by disorders of cholesterol synthesis. J. Lipid Res. 2011, 52:6-34.
102. Prasad M., Thomas J.L., Whittal R.M., Bose H.S. Mitochondrial 3-hydroxysteroid dehydrogenase enzyme activity requires reversible pH-dependent conformational changes at the intermembrane space. J. Biol. Chem. 2012, 287:9534-9546.
103. Riegelhaupt J.J., Waase M.P., Garbarino J., Cruz D.E., Breslow J.L. Targeted disruption of steroidogenic acute regulatory protein D4 leads to modest weight reduction and minor alterations in lipid metabolism. J. Lipid Res. 2010, 51:1134-1143.
104. Rodriguez-Agudo D., Ren S., Wong E., Marques D., Redford K., Gil G., Hylemon P.B., Pandak W.M. Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation. J. Lipid Res. 2008, 49:1409-1419.
105. Romanowski M.J., Soccio R.E., Breslow J.L., Burley S.K. Crystal structure of the Mus musculus cholesterol-regulated START protein 4 (StarD4) containing a StAR-related lipid transfer domain. Proc. Natl. Acad. Sci. USA 2002, 99:6949-6954.
106. Rone M.B., Liu J., Blonder J., Ye X., Veenstra T.D., Young J.C., Papadopoulos V. Targeting and insertion of the cholesterol-binding translocator protein into the outer mitochondrial membrane. Biochemistry 2009, 48:6909-6920.
107. Rone M.B., Midzak A.S., Issop L., Rammouz G., Jagannathan S., Fan J., Ye X., Blonder J., Veenstra T., Papadopoulos V. Identification of a dynamic mitochondrial protein complex driving cholesterol import, trafficking, and metabolism to steroid hormones. Mol. Endocrinol. 2012, 26:1868-1882.
108. Rubtsov P., Karmanov M., Sverdlova P., Spirin P., Tiulpakov A. A novel homozygous mutation in CYP11A1 gene is associated with late onset adrenal insufficiency and hypospadias in a 46 XY patient. J. Clin. Endocrinol. Metab. 2009, 94:936-939.
109. Saenger P., Klonari Z., Black S.M., Compagnone N., Mellon S.H., Fleischer A., Abrams C.A.L., Shackleton C.H.L., Miller W.L. Prenatal diagnosis of congenital lipoid adrenal hyperplasia. J. Clin. Endocrinol. Metab. 1995, 80:200-205.
110. Sahakitrungruang T., Tee M.K., Blackett P.R., Miller W.L. Partial defect in the cholesterol side-chain cleavage enzyme P450scc (CYP11A1) resembling nonclassic congenital lipoid adrenal hyperplasia. J. Clin. Endocrinol. Metab. 2011, 96:792-798.
111. Schimmer B.P., White P.C. Steroidogenic factor 1: its roles in differentiation, development and disease. Mol. Endocrinol. 2010, 24:1322-1337.
112. Schlingmann K.P., Kaufmann M., Weber S., Irwin A., Goos C., John U., Misselwitz J., Klaus G., Kuwertz-Broking E., Fehrenbach H., Wingen A.M., Guran T., Hoenderop J.G., Bindels R.J., Prosser D.E., Jones G., Konrad M. Mutations in CYP24A1 and idiopathic infantile hypercalcemia. N. Engl. J. Med. 2011, 365:410-421.
113. Sheftel A.D., Stehling O., Pierik A.J., Elsasser H.P., Muhlenhoff U., Webert H., Hobler A., Hannemann F., Bernhardt R., Lill R. Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe/S cluster biosynthesis. Proc. Natl. Acad. Sci. USA 2010, 107:11775-11780.
114. Shen W.J., Patel S., Natu V., Hong R., Wang J., Azhar S., Kraemer F.B. Interaction of hormone-sensitive lipase with steroidogenic acute regulatory protein. J. Biol. Chem. 2003, 278:43870-43876.
115. Solish S.B., Picado-Leonard J., Morel Y., Kuhn R.W., Mohandas T.K., Hanukoglu I., Miller W.L. Human adrenodoxin reductase: two mRNAs encoded by a single gene of chromosome 17cen→25 are expressed in steroidogenic tissues. Proc. Natl. Acad. Sci. USA 1988, 85:7104-7108.
116. Stevens V.L., Xu T., Lambeth J.D. Cholesterol pools in rat adrenal mitochondria: use of cholesterol oxidase to infer a complex pool structure. Endocrinology 1992, 130:1557-1563.
117. Stocco D.M., Clark B.J. Regulation of the acute production of steroids in steroidogenic cells. Endocr. Rev. 1996, 17:221-244.
118. Stocco D.M., Sodeman T.C. The 30kDa mitochondrial proteins induced by hormone stimulation in MA-10 mouse Leydig tumor cells are processed from larger precursors. J. Biol. Chem. 1991, 266:19731-19738.
119. Strushkevich N., MacKenzie F., Cherkesova T., Grabovec I., Usanov S., Park H.W. Structural basis for pregnenolone biosynthesis by the mitochondrial monooxygenase system. Proc. Natl. Acad. Sci. USA 2011, 108:10139-10143.
120. Sugawara T., Holt J.A., Driscoll D., Strauss J.F., Lin D., Miller W.L., Patterson D., Clancy K.P., Hart I.M., Clark B.J., Stocco D.M. Human steroidogenic acute regulatory protein (StAR): functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p11.2 and an expressed pseudogene to chromosome 13. Proc. Natl. Acad. Sci. USA 1995, 92:4778-4782.
121. Tajima T., Fujieda K., Kouda N., Nakae J., Miller W.L. Heterozygous mutation in the cholesterol side chain cleavage enzyme (P450scc) gene in a patient with 46, XY sex reversal and adrenal insufficiency. J. Clin. Endocrinol. Metab. 2001, 86:3820-3825.
122. Tee M.K., Abramsohn M., Loewenthal N., Harris M., Siwach S., Kaplinsky A., Markus B., Birk O., Sheffield V.C., Pavari R., Hershkovitz E., Miller W.L. Varied clinical presentations with mutations in CYP11A1 encoding the cholesterol side chain cleavage enzyme, P450scc. J. Clin. Endocrinol. Metab. 2013, 98:713-720.
123. Thomas J.L., Myers R.P., Strickler R.C. Human placental 3-hydroxy-5-ene-steroid dehydrogenase and steroid 5 δ 4-ene-isomerase: purification from mitochondria and kinetic profiles, biophysical characterization of the purified mitochondrial and microsomal enzymes. J. Steroid Biochem. 1989, 33:209-217.
124. Thorsell A.G., Lee W.H., Persson C., Siponen M.I., Nilsson M., Busam R.D., Kotenyova T., Schuler H., Lethio L. Comparative structural analysis of lipid binding START domains. PLoS ONE 2011, 6:e19521-e19532.
125. Tsujishita Y., Hurley J.H. Structure and lipid transport mechanism of a StAR-related domain. Nat. Struct. Biol. 2000, 7:408-414.
126. Tuckey R.C., Headlam M.J., Bose H.S., Miller W.L. Transfer of cholesterol between phospholipid vesicles mediated by the steroidogenic acute regulatory protein (StAR). J. Biol. Chem. 2002, 277:47123-47128.
127. Vanier M.T., Millat G. Niemann-Pick disease type C. Clin. Genet. 2003, 64:269-281.
128. Wang J.T., Lin C.J., Burridge S.M., Fu G.K., Labuda M., Portale A.A., Miller W.L. Genetics of vitamin D 1α-hydroxylase deficiency in 17 families. Am. J. Hum. Genet. 1998, 63:1694-1702.
129. White P.C., Curnow K.M., Pascoe L. Disorders of steroid 11-hydroxylase isozymes. Endocr. Rev. 1994, 15:421-438.
130. Xie Z.J., Munson S.J., Huang N., Portale A.A., Miller W.L., Bikle D.D. The mechanism of 1,25-dihydroxyvitamin D3 auto-regulation in keratinocytes. J. Biol. Chem. 2002, 277:36987-36990.
131. Xu S., Benoff B., Liou H.L., Lobel P., Stock A.M. Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease. J. Biol. Chem. 2007, 282:23525-23531.
132. Yang X., Iwamoto K., Wang M., Artwohl J., Mason J.I., Pang S. Inherited congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene encoding cytochrome P450 cholesterol side-chain cleavage enzyme. Endocrinology 1993, 132:1977-1982.
133. Yaworsky D.C., Baker B.Y., Bose H.S., Best K.B., Jensen L.B., Bell J.D., Baldwin M.A., Miller W.L. PH-dependent interactions of the carboxyl-terminal helix of steroidogenic acute regulatory protein with synthetic membranes. J. Biol. Chem. 2005, 280:2045-2054.
134. Zhang M., Liu P., Dwyer N.K., Christenson L.K., Fujimoto T., Martinez F., Comly M., Hanover J.A., Blanchette-Mackie E.J., Strauss J.F. MLN64 mediates mobilization of lysosomal cholesterol to steroidogenic mitochondria. J. Biol. Chem. 2002, 277:33300-33310.
135. Ziegler G.A., Vonrhein C., Hanukoglu I., Schulz G.E. The structure of adrenodoxin reductase of mitochondrial P450 systems: electron transfer for steroid biosynthesis. J. Mol. Biol. 1999, 289:981-990.